Medical/Pharmaceuticals
Mentice appoints Pontus Appelqvist as Vice President and GM for Asia Pacific
STOCKHOLM, April 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC), a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, today announced the appointment of Pontus Appelqvist as Vice President and General Manager forAsia Pacific. Po...
2021-04-15 16:21
2566
New clinical study shows JOYSBIO COVID-19 neutralizing antibody rapid test nearly 98% accurate in verifying antibodies after vaccination
TIANJIN, China, April 15, 2021 /PRNewswire/ -- In a major breakthrough for testing COVID-19 immunity, JOYSBIO, a Chinese medical device manufacturer, just announced the completion of a clinical study inItaly, showing their COVID-19 neutralizing antibody rapid test kit is 98.05% effective in detec...
2021-04-15 14:20
3318
Seegene's Italy subsidiary secures public procurement for 7.15 million COVID-19 diagnostic tests, the largest tender in history
* Seegene's Italian subsidiary to supply some 7.15 million COVID-19 tests to 17 regions there * S. Korean biotechnology firm to expand its influence in Italy's PCR diagnostic industry SEOUL, South Korea, April 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading molecular diagnostics ...
2021-04-15 14:19
2303
Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
HANGZHOU, China, April 14, 2021 /PRNewswire/ -- Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the global phase III clinical trial (BURAN) at Shanghai Eastern Hospital Medical Center inChin...
2021-04-15 09:00
2841
Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer
SHANGHAI, April 15, 2021 /PRNewswire/ -- Everest Medicines
2021-04-15 08:36
6454
Kintor Pharmaceutical and Visum Announced Strategic Partnership to Expand Proxalutamide Manufacturing
SUZHOU, China, April 14, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (stock code 9939.HK, "Kintor Pharmaceutical" or the "Company"), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, recently announced a strategic partnership with Hain...
2021-04-14 22:18
6163
Havas Health & You Strengthens Capabilities in Innovation and Customer Experience
Adds Network Chief Experience Officer Role and Co-Managing Directors of Innovation Engine, Havas NOW NEW YORK, April 14, 2021 /PRNewswire/ -- The last 12-18 months has dawned a new era in health, along with new expectations of companies across the health spectrum. Adding to the already fast-pace...
2021-04-14 21:35
1802
Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer
SHANGHAI, April 14, 2021 /PRNewswire/ -- Everest Medicines
2021-04-14 21:33
6974
Gannex Announces the First Cohort Dosed in a U.S. Clinical Study with THR-β Agonist ASC41
SHANGHAI, April 14, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces the dosing of the first cohort in the U.S. Phase I cli...
2021-04-14 20:00
5167
BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology
VANCOUVER, BC, April 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, is pleased to announce the results of a clinical study conducted by ProCare Health Iberia...
2021-04-14 20:00
8072
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery
SINGAPORE, April 14, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, dev...
2021-04-14 19:15
3261
New Study Reveals That Stress Causes People's Minds to Wander Close to 60% of the Workday
Sleep, purpose and a daily mind training practice are significant contributors to focus and productivity. NEW YORK, April 14, 2021 /PRNewswire/ -- People report that their minds wander at work 37% of the time, and stress increases mind-wandering by 2-3 times, according toThe Mind at Work study b...
2021-04-14 00:54
2226
Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public
PISCATAWAY, New Jersey and WEST SACRAMENTO, Calif., April 13, 2021 /PRNewswire/
--Molecular Matrix, Inc.
2021-04-13 19:30
2108
ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE™ Flexible Aseptic Isolator
NEWARK, Del., April 13, 2021 /PRNewswire/ -- ILC Dover LP ("ILC Dover" or the "Company"), specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing, today introduced the soloPURE™ flexible aseptic isolator, a c...
2021-04-13 18:00
3174
Harbour BioMed Presents Novel Antibody for Cancer Immunotherapy at 2021 American Association for Cancer Research Annual Meeting
CAMBRIDGE, Mass., SUZHOU, China and ROTTERDAM, Netherlands, April 13, 2021 /PRNewswire/ -- Harbour BioMed ("HBM"; HKEX: 02142.HK), a global clinical-stage biopharmaceutical company, presents its newly discovered fully human anti-B7H7 monoclonal antibody at the American Association for Cancer Rese...
2021-04-13 14:55
4297
MGI COVID-19 Container Lab Put to Test, Safeguarding the World Figure Skating Championships
STOCKHOLM, April 13, 2021 /PRNewswire/ -- The weeklong ISU World Figure Skating Championships (the Championships), an Olympic qualification event, were held in Stockholm, Sweden in late March. The world's top figure skaters from around the world had travelled toSweden to compete for the title of w...
2021-04-13 14:32
2140
Psychobiotic PS128 improves mood and sleep quality in its first clinical study on anxiety and stress
TAIPEI, April 13, 2021 /PRNewswire/ -- Bened Biomedical's psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a recent clinical trial. Participants were IT professionals under high levels of work-life stress. Psychobiotics are probiotics that yield specific mental healt...
2021-04-13 10:00
3683
Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021, with Results Signifying the Potential of Multiple Combination Therapies in Cancer
SUZHOU, China and ROCKVILLE, Md., April 13, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented the preclinical results of ...
2021-04-13 08:28
3095
Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021
SUZHOU, China, April 13, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from phase Ib/II clinical study (clinical trial No.: KN046-203) of PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel for the treatment of patients with metastatic trip...
2021-04-13 08:15
5057
Antengene Presented Preclinical Data Demonstrating Potent Synergistic Effect of the Combination of ATG-010 (Selinexor) and ATG-008 (Onatasertib) for the Treatment of Triple-Hit DLBCL
SHANGHAI, China and GAITHERSBURG, U.S., April 13, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in h...
2021-04-13 08:00
4279
Week's Top Stories
Most Reposted
UFO SIM Launches in Australia, The Ultimate Travel eSIM Starting at Just AU$2/GB
[Picked up by 310 media titles]
2026-04-01 11:03
Sustainable Tourism Impact Fund Expands Investments Across Southeast Asia
[Picked up by 309 media titles]
2026-04-03 11:30
Surfin Meta Digital Technology signs MOU with the Philippine Social Security System to explore digital financial service enhancements
[Picked up by 305 media titles]
2026-04-01 09:00
From Doomscroll to Page-Turner: BookXcess Launches The Brain Un-Rot Library to Help Rebuild a Generation's Focus
[Picked up by 302 media titles]
2026-03-31 13:53
DayOne Announces RM28+ Billion Commitment and Talent Initiatives in Malaysia at Inaugural Tech & AI Career Expo
[Picked up by 291 media titles]
2026-04-01 22:23
Most Read
Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq
2026-03-30 12:00
6703
